M John, S Lim, J Seybold, P Jose, A Robichaud, B O'Connor, PJ Barnes and KF Chung
National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom.

We determined the effect of inhaled corticosteroid, budesonide, on the release of the anti-inflammatory cytokine, interleukin-10 (IL-10), and of pro-inflammatory cytokines, macrophage inflammatory protein-1alpha (MIP-1alpha), interferon-gamma (IFN-gamma), and granulocyte-macrophage colony-stimulating factor (GM-CSF), from blood monocytes and alveolar macrophages of mild asthmatic subjects in a double-blind, cross-over, placebo-controlled study. Budesonide reduced bronchial hyperresponsiveness and improved baseline FEV1. Alveolar macrophages were obtained by bronchoalveolar lavage performed at the end of each treatment phase. IL-10 from blood monocytes was not altered, but both IL-10 mRNA and protein expression from alveolar macrophages stimulated by lipopolysaccharide and IL-1beta were increased after corticosteroid therapy. By contrast, alveolar macrophages released significantly less MIP-1alpha, IFN-gamma, and GM-CSF after steroid treatment. In comparison to alveolar macrophages from normal nonasthmatic volunteers, those from asthmatic patients released more MIP-1alpha, IFN-gamma, and GM-CSF but lower amounts of IL-10 particularly at baseline and after IL- 1beta stimulation. The ability of steroids to inhibit pro-inflammatory cytokines but to enhance the anti-inflammatory cytokine such as IL-10 may contribute to their beneficial actions in asthma. Asthma is characterized by alveolar macrophages exhibiting both an enhanced capacity to release pro-inflammatory cytokines and a reduced capacity to produce IL-10.

This article has been cited by other articles:

				S. V. Culpitt, D. F. Rogers, P. Shah, C. De Matos, R. E. K. Russell, L. E. Donnelly, and P. J. Barnes Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 24 - 31. [Abstract] [Full Text] [PDF]

				W. Mattos, S. Lim, R. Russell, A. Jatakanon, K. F. Chung, and P. J. Barnes Matrix Metalloproteinase-9 Expression in Asthma: Effect of Asthma Severity, Allergen Challenge, and Inhaled Corticosteroids Chest, November 1, 2002; 122(5): 1543 - 1552. [Abstract] [Full Text] [PDF]

				E. Careau, J. Sirois, and E. Y. Bissonnette Characterization of Lung Hyperresponsiveness, Inflammation, and Alveolar Macrophage Mediator Production in Allergy Resistant and Susceptible Rats Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 579 - 586. [Abstract] [Full Text] [PDF]

				P. J. Smith, D. J. Cousins, Y.-K. Jee, D. Z. Staynov, T. H. Lee, and P. Lavender Suppression of Granulocyte-Macrophage Colony-Stimulating Factor Expression by Glucocorticoids Involves Inhibition of Enhancer Function by the Glucocorticoid Receptor Binding to Composite NF-AT/Activator Protein-1 Elements J. Immunol., September 1, 2001; 167(5): 2502 - 2510. [Abstract] [Full Text] [PDF]

				N. P. O'GRADY, H. L. PREAS II, J. PUGIN, C. FIUZA, M. TROPEA, D. REDA, S. M. BANKS, and A. F. SUFFREDINI Local Inflammatory Responses following Bronchial Endotoxin Instillation in Humans Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1591 - 1598. [Abstract] [Full Text] [PDF]

				E. Crawley, S. Kon, and P. Woo Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis Rheumatology, May 1, 2001; 40(5): 574 - 578. [Abstract] [Full Text] [PDF]

				G. M. GAUVREAU, L. J. WOOD, R. SEHMI, R. M. WATSON, S. C. DORMAN, R. P. SCHLEIMER, J. A. DENBURG, and P. M. O'BYRNE The Effects of Inhaled Budesonide on Circulating Eosinophil Progenitors and Their Expression of Cytokines after Allergen Challenge in Subjects with Atopic Asthma Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2139 - 2144. [Abstract] [Full Text]

				S. LIM, N. ROCHE, B. G. OLIVER, W. MATTOS, P. J. BARNES, and K. FAN CHUNG Balance of Matrix Metalloprotease-9 and Tissue Inhibitor of Metalloprotease-1 from Alveolar Macrophages in Cigarette Smokers . Regulation by Interleukin-10 Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1355 - 1360. [Abstract] [Full Text] [PDF]

				M J Plummeridge, L Armstrong, M A Birchall, and A B Millar Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects Thorax, October 1, 2000; 55(10): 842 - 847. [Abstract] [Full Text]

				C. MARGUET, T. P. DEAN, and J. O. WARNER Soluble Intercellular Adhesion Molecule-1 (sICAM-1) and Interferon-Gamma in Bronchoalveolar Lavage Fluid from Children with Airway Diseases Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1016 - 1022. [Abstract] [Full Text]

				C. T. LEONARD, P. M. SOCCAL, L. SINGER, G. J. BERRY, J. THEODORE, P. G. HOLT, R. L. DOYLE, and G. D. ROSEN Dendritic Cells and Macrophages in Lung Allografts . A Role in Chronic Rejection? Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1349 - 1354. [Abstract] [Full Text]

				P. J. BARNES Endogenous Inhibitory Mechanisms in Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181. [Full Text] [PDF]

				C. M. Hogaboam, K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, and N. W. Lukacs Chronic Airway Hyperreactivity, Goblet Cell Hyperplasia, and Peribronchial Fibrosis during Allergic Airway Disease Induced by Aspergillus fumigatus Am. J. Pathol., February 1, 2000; 156(2): 723 - 732. [Abstract] [Full Text] [PDF]

				D. T. Umetsu and R. H. DeKruyff Interleukin-10 . The Missing Link in Asthma Regulation? Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 562 - 563. [Full Text]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]